If you need more lookups,
subscriptions start at $34 USD/month.
Andrew Boden Location
United Kingdom
Andrew Boden Work
Associate Director, Site Alliances @ (April 2021 - Present)
Senior Manager, Clinical Operations @ (June 2016 - April 2021)
Manager Clinical Operations @ (February 2014 - May 2016)
Associate Clinical Project Management Director @ (July 2012 - June 2013)
Associate Director, Budgeting and Strategy Implementation @ (July 2010 - July 2012)
Manager Clinical Operations @ (February 2007 - July 2010)
Clinical Team Leader @ (December 2004 - October 2006)
CRA (Experimental Medicine) @ (October 2002 - December 2004)
Training Consultant @ FW Pharma Systems (May 2000 - October 2002)
CRA (Phase II -III) @ (May 1999 - May 2000)
Clinical Research Associate @ Mitsubishi Pharma Europe (January 1998 - January 1999)
Andrew Boden Education
University of Birmingham
PhD (Sport and Exercise Sciences (Respiratory Physiology))
1994-1998
The University of Aberdeen
MSc (by research) (Human and Animal Physiology)
1993-1994
The University of Portsmouth
BSc (Biology)
1990-1993
Andrew Boden Skills
Clinical Monitoring
Pharmaceutical Industry
Clinical Trials
Sop
ICH-GCP
CRO
CTMS
Clinical Research
GCP
Therapeutic Areas
Clinical Operations
Protocol
Infectious Diseases
Drug Development
EDC
Trial Management
CRO Management
Clinical Trial Management System (CTMS)
Marketing
Hospitals
Strategy
Clinical Trial Management System Ctms
Ich Gcp
Business Analysis
Strategic Planning
Clinical Trial Management System
Andrew Boden Summary
Andrew Boden, based in United Kingdom, is currently a Associate Director, Site Alliances at Parexel. Andrew Boden brings experience from previous roles at Parexel and Quintiles. Andrew Boden holds a 1994 - 1998 PhD in Sport and Exercise Sciences (Respiratory Physiology) @ University of Birmingham. With a robust skill set that includes Clinical Monitoring, Pharmaceutical Industry, Clinical Trials, Sop, ICH-GCP and more. Andrew Boden has 2 emails on RocketReach.
Looking for a different Andrew Boden?
Find contact details for 700 million professionals.